|
Sign In to gain access to subscriptions and/or personal tools.
|
Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells
Jawahar L Mehta
Departments of Medicine and Physiology and Biophysics, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA, mehtajl@ uams.edu
Dayuan Li
Departments of Medicine and Physiology and Biophysics, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA
Background Several studies have shown that angiotensin II (Ang II) and oxidised low-density lipoprotein (ox-LDL) are critical factors in atherosclerosis. In this study, we examined the molecular basis of mutually facilitative interactions between Ang II and ox-LDL in human coronary artery endothelial cells (HCAECs).
Methods and results We observed that incubation of cultured HCAECs with Ang II (10-12 to 10-6 M) for 24 hours caused a concentration-dependent increase in the expression of mRNA and protein of a specialised receptor for ox-LDL (LOX-1). These effects of Ang II were completely blocked by pretreatment of HCAECs with candesartan (10-6 M), a specific AT1-receptor blocker, but not by PD 123319 (10-6 M), a specific AT2-receptor blocker. On the other hand, incubation of HCAECs with ox-LDL (10 and 40 µg/ml) for 24 hours progressively upregulated AT1-, but not AT 2-, receptor mRNA and protein. Pretreatment of cells with the anti-oxidant alpha-tocopherol (1—5 x 10-6 M) inhibited the upregulation of AT1-receptor expression induced by ox-LDL (p<0.05). To determine the significance of expression of AT1-receptors and LOX-1, we measured cell injury in response to Ang II and ox-LDL. Incubation of cells with both ox-LDL and Ang II synergistically increased cell injury, measured as cell viability and LDH release, compared with either ox-LDL or Ang II alone (both p<0.05). Alpha-tocopherol, as well as candesartan, attenuated cell injury in response to Ang II and ox-LDL (both p<0.05).
Conclusions These observations show that Ang II upregulates a novel endothelial receptor for ox-LDL (LOX-1) gene expression and ox-LDL in turn upregulates Ang II AT 1receptor gene expression. This interaction between Ang II and ox-LDL further augments cell injury in HCAECs. These findings provide basis for the use of AT1-receptor blockers and anti-oxidants in designing therapy for atherosclerosis and myocardial ischaemia.
Key Words: angiotensin II oxidised-LDL receptors endothelial cells
References
- Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:23-8.
- Schumacher M., Eber B.,Tatzber F., Kaufmann P., Halwachs G., Fruhwald FM Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Rad Biol Med 1995;18:1087-91.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Harrison GJ, Jordan L., Selley M., Willis R. Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts. Heart Vessels 1995;10:249-57.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Li DY,Yang BC, Mehta JL Oxidized low density lipoprotein induces apoptosis in cultured human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol 1998;275:H568-H576.[Web of Science][Medline]
[Order article via Infotrieve]
- Li DY, Mehta JL Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells. Evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000;20:1116-22.[Abstract/Free Full Text]
- Li DY, Mehta JL Antisense to LOX-1 inhibits oxidized LDLmediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000;101:2889-95.[Abstract/Free Full Text]
- Chen LY, Mehta P., Mehta JL Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: Relevance of the effect of oxidized LDL on platlet function. Circulation 1996;93:1740-6.[Abstract/Free Full Text]
- Sawamura T., Kume N., Aoyama T. et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- MuraseT, Kume N., Korenaga R. et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:328-33.[Abstract/Free Full Text]
- Kume N., Murase T., Moriwaki H. et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:322-7.[Abstract/Free Full Text]
- Mehta JL, Li DY Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998;248:511-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kataoka H.,Kume N.,Miyamoto S. et al. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999;99:3110-7.[Abstract/Free Full Text]
- Feolde E., Vigne P., Frelin C. Angiotensin II receptor subtypes and biological responses in the rat heart. J Mol Cell Cardiol 1993;25:1359-67.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yang BC, Phillips MI, Ambuehl PEJ, Sheen LP, Mehta P., Mehta JL Increase in angiotensin II type 1 receptor expression immediately following ischemia-reperfusion in isolated rat hearts. Circulation 1997;96:922-6.[Abstract/Free Full Text]
- Timmermans PB, Smith RD Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 1994;15(Suppl D):79-87.[Abstract]
- Yamada T., Horiuchi M., Dzau VJ Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-60.[Abstract/Free Full Text]
- Li DY,Yang BC, Philips MI, Mehta JL Pro-apoptotic effects of angiotensin II in human coronary artery endothelial cells: Role of AT1R receptor and PKC activation. Am J Physiol 1999;276:H786-H792.[Web of Science][Medline]
[Order article via Infotrieve]
- Nickenig G., Bohm M. Regulation of the angiotensin AT1R receptor expression by hypercholesterolemia. Eur J Med Res 1997;2:285-9.[Medline]
[Order article via Infotrieve]
- Keidar S., Kaplan M., Hoffman A. and Aviram M. Angiotensin II stimulates macrophages-mediated oxidation of low density lipoproteins. Atherosclerosis 1995;115:201-15.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Keidar S., Attias J. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway. Biochem Biophys Res Commun 1997;239:63-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fareh J.,Touyz RM, Schiffrin EL,Thibault G. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart: Receptor regulation and intracellular Ca2+ modulation. Circ Res 1995;78:302-11.[Web of Science]
- Regitz-Zagrosek V., Friedel N., Heymann A. et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91:1461-71.[Abstract/Free Full Text]
- Regitz-Zagrosek V., Fielitz J., Dreysse R., Hildebrandt AG, Fleck E. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovasc Res 1997;35:99-105.[Abstract/Free Full Text]
- Harada K., Komuro I., Hayashi D., Sngaya T., Murakami K., Yazaki Y. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 1998;97:315-7.[Abstract/Free Full Text]
- Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher AMAngiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997;81:970-6.[Abstract/Free Full Text]
- Nickenig G., Jung O., Strehlow K. et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am JPhysiol 1997;272: H2701-H2707.[Web of Science][Medline]
[Order article via Infotrieve]
- Yang BC, Phillips MI, Mohuczy D. et al. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler, Thromb and Vasc Biol 1998;18:1433-9.[Abstract/Free Full Text]
- Chen H., Li D., SawamuraT., Inoue K., Mehta JL Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun 2000;276:1100-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bickel PE, Freeman MW Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 1992;90:1450-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Kume N.,Arai H., Kawai C., Kita T. Receptors for modified low density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim Biophys Acta 1991;1091:63-7.[Medline]
[Order article via Infotrieve]
- Nagase M., Hirose S., Sawamura T., Tomoh M., Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 1997;237:496-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nickenig G., Sachinidis A., Michaelsen F., Bohm M., Seewald S., Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells. Circulation 1997;95:473-8.[Abstract/Free Full Text]
- Pitt B., Segal R., Martinez FA et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of losartan in the elderly study (ELITE). Lancet 1997;349:747-52.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Berkenboom G., Langer I., Carpentier Y., Grosfils K., Fontaine J. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism.Hypertension 1997;30(3 Pt 1):371-6.[Abstract/Free Full Text]
- Rangaswamy S., Penn MS, Saidel GM, Chisolm GM Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 1997;80:37-44.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl,
S70-S76 (2001)
DOI: 10.1177/14703203010020011201

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|